From February 18, 2022 to March 31, 2022, the company has repurchased 173,710 shares, representing 2.46% for KRW 2,889.7 million. With this, the company has completed the repurchase of 173,710 shares, representing 2.46% for KRW 2,889.7 million under the buyback announced on February 18, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16,280 KRW | +12.66% |
|
+23.99% | +45.10% |
1st Jan change | Capi. | |
---|---|---|
+45.10% | 80.58M | |
+20.82% | 127B | |
+21.96% | 116B | |
+23.06% | 27.69B | |
-22.97% | 19.62B | |
-17.12% | 16.26B | |
-19.03% | 15.49B | |
+11.66% | 14.81B | |
-48.41% | 14.39B | |
+54.78% | 14.11B |
- Stock Market
- Equities
- A049960 Stock
- News Cell Biotech Co., Ltd.
- Tranche Update on Cell Biotech Co., Ltd.'s Equity Buyback Plan announced on February 18, 2022.